What is Elo?
Elo operates as a Smart Nutrition company that utilizes proprietary data models to deliver hyper-personalized health interventions. By analyzing individual biomarkers and lifestyle data, the platform provides users with tailored nutritional guidance designed to optimize metabolic health and longevity. The company's market position is defined by its ability to synthesize complex health data into accessible, consumer-friendly applications, effectively disrupting traditional dietary paradigms. With a leadership team boasting deep expertise in both hardware and software ecosystems, Elo is uniquely equipped to scale its operations within the competitive health-tech landscape, targeting a growing demographic of health-conscious consumers seeking evidence-based wellness solutions.
How much funding has Elo raised?
Elo has raised a total of $15M across 2 funding rounds:
Angel/Seed
$5M
Series A
$10M
Angel/Seed (2022): $5M with participation from Will Ventures, Stormbreaker, Gullspång Re:food, and Proxy
Series A (2023): $10M led by Gullspång Re:food, Will Ventures, and Octopus Ventures
Key Investors in Elo
Gullspång Re:food
Re:food is a transatlantic growth equity investor focused on supporting visionary food companies that address global challenges in the food system through agrifood investments.
Will Ventures
Will Ventures is an investment firm focused on early-stage consumer, health, and media startups, leveraging a hustle-first mentality to support category-defining businesses.
Octopus Ventures
Octopus Ventures is a founder-focused venture capital firm backing mission-driven companies across software, climate, health, and financial technology.
What's next for Elo?
With the recent influx of capital, Elo is poised to accelerate its product development roadmap and expand its market reach. The strategic focus will likely center on enhancing its data-processing capabilities and deepening its integration with wearable health technologies to provide real-time nutritional feedback. As the company scales, it will continue to leverage its partnerships with specialized investors to refine its go-to-market strategy and solidify its status as a category leader in the personalized medicine space. Future growth will be driven by the continued adoption of its platform, as Elo seeks to establish a new standard for how data-driven nutrition can mitigate chronic disease and improve long-term health outcomes on a global scale.
See full Elo company page
